Cas:149926-91-0 Revatropate manufacturer & supplier

We serve Chemical Name:Revatropate CAS:149926-91-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Revatropate

Chemical Name:Revatropate
CAS.NO:149926-91-0
Synonyms:(3R-(3R*(S*(R*))))-1-Azabicyclo[2.2.2]oct-3-yl a-(Hydroxymethyl)-a-(2-(methylsulfinyl)ethyl)benzenacetate;Benzeneacetic acid, α-(hydroxymethyl)-α-[2-[(R)-(1R)-methylsulfinyl]ethyl]-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, (αS)-;UNII:3W7L15V40W;Unii-3W7L15V40w;Uk-112,166;Revatropate;(R)-Quinuclidinyl (2S)-2-b-Hydroxy-a-(2-((R)-methylsulfinyl)ethyl)hydratropate;(3R)-1-Azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-[(R)-methylsulfinyl]-2-phenylbutanoate
Molecular Formula:C19H27NO4S
Molecular Weight:365.487
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:581.5±50.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.614
PSA:86.05000
Exact Mass:365.166077
LogP:0.46

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (3R-(3R*(S*(R*))))-1-Azabicyclo[2.2.2]oct-3-yl a-(Hydroxymethyl)-a-(2-(methylsulfinyl)ethyl)benzenacetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3R)-1-Azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-[(R)-methylsulfinyl]-2-phenylbutanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3R)-1-Azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-[(R)-methylsulfinyl]-2-phenylbutanoate Use and application,UNII:3W7L15V40W technical grade,usp/ep/jp grade.


Related News: From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend. Revatropate manufacturer For example, an active ingredient to relieve pain is included in a painkiller. Revatropate supplier Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. Revatropate vendor Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control. Revatropate factory From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.